Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

Anti-Vascular Endothelial Growth Factor Therapy in Breast Cancer

Neo-angiogenesis is a critical process for tumor growth and invasion and has become a promising target in cancer therapy. This manuscript reviews three currently relevant anti-angiogenic agents targeting the vascular endothelial growth factor system: bevacizumab, ramucirumab and sorafenib. The effic...

Full description

Bibliographic Details
Main Authors: Tina Bøgelund Kristensen, Malin L. T. Knutsson, Markus Wehland, Britt Elmedal Laursen, Daniela Grimm, Elisabeth Warnke, Nils E. Magnusson
Format: Article
Language:English
Published: MDPI AG 2014-12-01
Series:International Journal of Molecular Sciences
Subjects:
breast cancer
anti-angiogenic therapy
biomarkers
vascular endothelial growth factor
Online Access:http://www.mdpi.com/1422-0067/15/12/23024

Internet

http://www.mdpi.com/1422-0067/15/12/23024

Similar Items